{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:59:52Z","timestamp":1777543192278,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jcv.2023.105619","type":"journal-article","created":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:45:01Z","timestamp":1700527501000},"page":"105619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["HTLV-1-associated myelopathy in Spain"],"prefix":"10.1016","volume":"169","author":[{"given":"Carmen","family":"de-Mendoza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leire","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariadna","family":"Rando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Reina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Benito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Eir\u00f3s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itziar","family":"Rodr\u00edguez-Avial","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Pozuelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Pena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2023.105619_bib0001","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00078-21","article-title":"Clinical and public health implications of HTLV-1 infection","volume":"35","author":"Legrand","year":"2022","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jcv.2023.105619_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1043600","article-title":"Geographic distribution, clinical epidemiology and genetic diversity of the human oncogenic retrovirus HTLV-1 in Africa, the world's largest endemic area","volume":"14","author":"Gessain","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jcv.2023.105619_bib0003","doi-asserted-by":"crossref","first-page":"211","DOI":"10.24875\/AIDSRev.19000108","article-title":"HTLV-1 associated neurological complex: what is hidden below the water?","volume":"21","author":"Araujo","year":"2019","journal-title":"AIDS Rev."},{"key":"10.1016\/j.jcv.2023.105619_bib0004","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/S1473-3099(20)30328-5","article-title":"HTLV-1: a lifelong persistent infection, yet never truly silent","volume":"21","author":"Hirons","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jcv.2023.105619_bib0005","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","article-title":"Antibodies to HTLV-1 in patients with tropical spastic paraparesis","volume":"2","author":"Gessain","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2023.105619_bib0006","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neurol.2011.12.006","article-title":"Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects","volume":"168","author":"Gessain","year":"2012","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.jcv.2023.105619_bib0007","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s13023-019-1212-4","article-title":"Real-world clinical course of HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) in Japan","volume":"14","author":"Tsutsumi","year":"2019","journal-title":"Orphanet. J. Rare. Dis."},{"key":"10.1016\/j.jcv.2023.105619_bib0008","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1001\/archneur.63.11.1560","article-title":"Natural history of HTLV-1-associated myelopathy: a 14-year follow-up study","volume":"63","author":"Olindo","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jcv.2023.105619_bib0009","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/13550280600827336","article-title":"Clinical symptoms and the odds of HAM\/TSP in healthy virus carriers: application of best-fit logistic regression equation based on host genotype, age, and provirus load","volume":"12","author":"Nose","year":"2006","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.jcv.2023.105619_bib0010","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1097\/QAD.0000000000001527","article-title":"Spanish HTLV Network. Human T-lymphotropic virus type 1 infection and disease in Spain","volume":"31","author":"de Mendoza","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.jcv.2023.105619_bib0011","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/QAD.0000000000002508","article-title":"Spanish HTLV Network. Hospital admissions in individuals with HTLV-1 infection in Spain","volume":"34","author":"Ramos","year":"2020","journal-title":"AIDS"},{"key":"10.1016\/j.jcv.2023.105619_bib0012","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1473-3099(20)30133-X","article-title":"HTLV-1 infection and health outcomes","volume":"20","author":"Ramos","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jcv.2023.105619_bib0013","doi-asserted-by":"crossref","first-page":"e28779","DOI":"10.1002\/jmv.28779","article-title":"The slowdown of new infections by human retroviruses has reached a plateau in Spain","volume":"95","author":"de Mendoza","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jcv.2023.105619_bib0014","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1089\/aid.2006.22.931","article-title":"Proposal for diagnostic criteria of tropical spastic paraparesis\/HTLV-I-associated myelopathy (TSP\/HAM)","volume":"22","author":"Castro-Costa","year":"2006","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.jcv.2023.105619_bib0015","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3389\/fmicb.2018.01651","article-title":"Proposal of classification criteria for HTLV-1-associated myelopathy\/tropical spastic paraparesis disease activity","volume":"9","author":"Sato","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jcv.2023.105619_bib0016","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0140-6736(90)93422-L","article-title":"HTLV-1 in Spain","volume":"336","author":"Soriano","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2023.105619_bib0017","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00007890-200301150-00019","article-title":"Rapid development of subacute myelopathy in three organ transplant recipients after transmission of HTLV-1 from a single donor","volume":"75","author":"Toro","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.jcv.2023.105619_bib0018","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/jmv.20331","article-title":"Infection with HTLV-1 in organ transplant donors and recipients in Spain","volume":"76","author":"Toro","year":"2005","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jcv.2023.105619_bib0019","article-title":"Rapid subacute myelopathy following kidney transplantation from HTLV-1 donors: role of immunosuppressors and failure of antiretrovirals","volume":"6","author":"Roc","year":"2019","journal-title":"Ther. Adv. Infect. Dis."},{"key":"10.1016\/j.jcv.2023.105619_bib0020","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1186\/s12879-019-4346-z","article-title":"Spanish HTLV Network. HTLV-1 infection in solid organ transplant donors and recipients in Spain","volume":"19","author":"de Mendoza","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.jcv.2023.105619_bib0021","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00126334-200006010-00017","article-title":"In vivo fluctuation of HTLV-I and HTLV-II proviral load in patients receiving antiretroviral drugs","volume":"24","author":"Machuca","year":"2000","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.jcv.2023.105619_bib0022","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0168-1702(01)00287-8","article-title":"The effect of antiretroviral therapy on HTLV infection","volume":"78","author":"Machuca","year":"2001","journal-title":"Virus Res."},{"key":"10.1016\/j.jcv.2023.105619_bib0023","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/jac\/dkr404","article-title":"Antiviral effect of raltegravir on HTLV-1 carriers","volume":"67","author":"Trevi\u00f1o","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jcv.2023.105619_bib0024","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1080\/22221751.2020.1752117","article-title":"Multiple recombinant events in HTLV-1: complete sequences of recombinant African strains","volume":"9","author":"Cassar","year":"2020","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.jcv.2023.105619_bib0025","doi-asserted-by":"crossref","first-page":"E40","DOI":"10.3390\/v8020040","article-title":"Mother-to-child transmission of HTLV-1: epidemiological aspects, mechanisms and determinants of mother-to-child transmission","volume":"8","author":"Percher","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.jcv.2023.105619_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2022.105324","article-title":"Increasing horizontal transmission of HTLV type 1 in adolescents and young adults in Japan","volume":"157","author":"Sagara","year":"2022","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2023.105619_bib0027","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.virusres.2019.04.004","article-title":"Spanish HTLV network. HIV co-infection in HTLV-1 carriers in Spain","volume":"266","author":"de Mendoza","year":"2019","journal-title":"Virus Res."},{"key":"10.1016\/j.jcv.2023.105619_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171303","article-title":"HTLV-1 is predominantly sexually transmitted in Salvador, the city with the highest HTLV-1 prevalence in Brazil","volume":"12","author":"Nunes","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jcv.2023.105619_bib0029","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.167422","article-title":"Identification and tracking of HTLV-1-infected T cell clones in virus-associated neurologic disease","volume":"8","author":"Nozuma","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.jcv.2023.105619_bib0030","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1089\/aid.2022.0028","article-title":"HTLV-1-associated myelopathy: overview of HTLV-1\/2 tests and potential biomarkers","volume":"38","author":"Puccioni-Sohler","year":"2022","journal-title":"AIDS Res. Hum. Retroviruse."},{"key":"10.1016\/j.jcv.2023.105619_bib0031","doi-asserted-by":"crossref","DOI":"10.1212\/CPJ.0000000000200147","article-title":"Imaging spectrum of HTLV-1-related neurologic disease: a pooled series and review","volume":"13","author":"Dixon","year":"2023","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.jcv.2023.105619_bib0032","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cis343","article-title":"Development of tropical spastic paraparesis in HTLV-1 carriers is influenced by interleukin 28B gene polymorphisms","volume":"55","author":"Trevi\u00f1o","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2023.105619_bib0033","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1007\/s00415-013-7014-z","article-title":"Association between HLA alleles and HAM\/TSP in individuals infected with HTLV-1","volume":"260","author":"Trevi\u00f1o","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.jcv.2023.105619_bib0034","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s13311-015-0369-3","article-title":"Triple therapy with prednisolone, pegylated interferon and sodium valproate improves clinical outcome and reduces HTLV-1 proviral load, Tax and HBZ mRNA expression in patients with HTLV-1-associated myelopathy\/tropical spastic paraparesis","volume":"12","author":"Boostani","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jcv.2023.105619_bib0035","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1212\/CPJ.0000000000000832","article-title":"Management of HAM\/TSP: systematic review and consensus-based recommendations 2019","volume":"11","author":"Araujo","year":"2021","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.jcv.2023.105619_bib0036","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3390\/v14010136","article-title":"Efficacy of corticosteroid therapy for HTLV-1-associated myelopathy: a randomized controlled trial (HAMLET-P)","volume":"14","author":"Yamauchi","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.jcv.2023.105619_bib0037","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMoa1704827","article-title":"Mogamulizumab (anti-CCR4) in HTLV-1-associated myelopathy","volume":"378","author":"Sato","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2023.105619_bib0038","first-page":"ciad281","article-title":"Mogamulizumab for treatment of HTLV-1-associated myelopathy\/tropical spastic paraparesis: a single-center US-based series","volume":"9","author":"Meyerowitz","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2023.105619_bib0039","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awad139","article-title":"Long-term safety and efficacy of mogamulizumab (anti-CCR4) for treating virus-associated myelopathy","author":"Sato","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.jcv.2023.105619_bib0040","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.ijid.2022.07.043","article-title":"Late presentation of HTLV-1 infection in Spain reflects suboptimal testing strategies","volume":"122","author":"de Mendoza","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.jcv.2023.105619_bib0041","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.897346","article-title":"The past, present, and future of a HTLV-1 vaccine","volume":"13","author":"Tu","year":"2022","journal-title":"Front. Microbiol."},{"issue":"suppl. 1","key":"10.1016\/j.jcv.2023.105619_bib0042","first-page":"6","article-title":"HTLV infection in persons with sexually transmitted diseases in Spain","volume":"25","author":"Ayerdi","year":"2023","journal-title":"AIDS Rev."},{"issue":"suppl. 1","key":"10.1016\/j.jcv.2023.105619_bib0043","first-page":"7","article-title":"High rate of HTLV-1 infection among Latin American pregnant women living in Spain","volume":"25","author":"Encinas","year":"2023","journal-title":"AIDS Rev."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653223002421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653223002421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:17:57Z","timestamp":1761362277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653223002421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":43,"alternative-id":["S1386653223002421"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2023.105619","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HTLV-1-associated myelopathy in Spain","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2023.105619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105619"}}